Editorial: Next generation in vitro models of the human blood - brain/cerebrospinal fluid barrier
- PMID: 38352192
- PMCID: PMC10861790
- DOI: 10.3389/fnmol.2024.1371733
Editorial: Next generation in vitro models of the human blood - brain/cerebrospinal fluid barrier
Keywords: drug discovery; lab-on-a-chip; neurodegenerative diseases; neuroscience; stem cells.
Conflict of interest statement
SW is the C.E.O. of Axolotl Biosciences—a biotechnology company that sells novel bioinks. EK is an employee of STEMCELL Technologies Canada Ltd.—a biotechnology company that sells cell culture media, instruments, and cell separation reagents. RD is an employee of Emulate Bio Inc. U.S.A—a biotechnology company that sells microphysiological systems, platforms, and biological kits for organ on chip models. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Next generation in vitro models of the human blood - brain/cerebrospinal fluid barrier
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous